BioNTech (United States)

BioNTech (United States)

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for BioNTech (United States), United States, covering academic research published from 2003 to 2024. Read More.


Open Access Percentage

69%


Total
Publications

120


Total Open
Publications

83


Total
Citations

4.6K


Open Access
Percentage

69%


Total
Publications

120


Total Open
Publications

83


Total
Citations

4.6K

Wikipedia

Website

download

Breakdown

25% 21% 20% 34%

Publisher Open

25%

Both

21%

Other Platform Open

20%

Closed

34%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618202224262830Total Publications
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

36%OA Journal

OA Journal 36%

18

Hybrid 34%

17

No Guarantees 30%

15

Other Platform Open

Domain 52%

24

Preprint 39%

18

Other Internet 7%

3

Public 2%

1

Institution 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
24
bioRxiv
Preprint
9
medRxiv
Preprint
6
Research Square
Preprint
3
DOI
Other Internet
3
Figshare
Public
1
1 / 1

Data updated 18 August 2025

Share

Share

Share